Article
Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile.
PloS one - 1 Jan 2026
Armijo Nicolas, Espinoza Manuel A, Contreras-Montiel Pilar, Vera Macarena, Balmaceda Carlos
Abstract excerpt
Testing for high-risk human papillomavirus with genotyping for types 16 and 18 (HPV16/18) and triage by p16/Ki-67 dual-stain immunocytochemistry improves diagnostic performance in cervical cancer screening. We estimated the cost-effectiveness of HPV DNA-based primary screening strategies that detect high-risk genotypes every 5 years with either reflex cytology (hrHPV-Pap-5) or reflex dual stain (CINtec® PLUS,...
Topics
Join the communities discussing this publication.
